CLARITY PHARMACEUTICALS
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Clarity Pharmaceuticals closes $25m capital raising 2020-12-15 22:12
Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma 2020-09-09 21:13
Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial 2020-07-23 21:13
Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets 2020-07-21 21:13
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma 2020-06-03 21:08
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma 2020-04-21 21:13
Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group 2020-03-31 12:10
Prof. Oliver Sartor Joins Clarity's Advisory Board 2020-03-20 12:29
Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board 2019-04-10 09:30
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board 2019-03-26 08:30
1 2 3